Taken together, our study demonstrates that disease-regulated therapy mediated by IL-10 has a beneficial outcome on arthritis development in CIA and provides a step towards disease-regulated therapies in human autoimmune arthritis. This evidence concerns the gene IL10 and arthritic joint disease.